FDA Clears New Features in AI-Powered Mammography Software Suite

A new version of an AI-enabled mammography software may enhance breast cancer detection and bolster workflow efficiency for mammography assessment.

Therapixel’s updated MammoScreen suite has garnered new 510(k) clearances for breast density evaluation and new software that offers a variety of features to help reduce workflow bottlenecks for radiologists.

The company said key features include the ability to organize the day’s worklist through a case complexity index; an algorithm that facilitates assessment of 2D and 3D breast imaging and a patient’s prior history; and automated pre-reporting that facilitates enhanced efficiency with reporting of mammography findings.

“With these new features, radiologists can double their reading time savings compared to the previous version. Radiologists will appreciate the reduced fatigue, administrators the improved efficiency and care consistency, and the IT team the seamless one-time installation. We’re proud to launch this new version of MammoScreen, once again delivering unparalleled value to radiologists and patients,” noted Matthieu Leclerc-Chalvet, the chief executive officer of Therapixel.